New data show that lecanemab is well tolerated outside of clinical trial setting, with expected and manageable side effects.

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have ...

A supportive government, modern infrastructure and easily accessible patient population are helping this Asian nation become a top location for clinical trial research. South Korea, a country in ...

The analysis of 3 dozen studies found similarities and differences in motivating factors for and against clinical trial ...

At the same time, a growing trend toward the use of basket and umbrella trials has been observed. Such designs offer a ...

The likelihood for avoidance of five clinically important outcomes in patients with COPD and type 2 inflammation was greater with dupilumab vs. placebo, according to findings from a win ratio analysis ...

Background Acute coronary syndrome (ACS) is a global leading cause of morbidity, with residual inflammation contributing to ...

A recent analysis reveals that ellipsoidal zone-retinal pigment epithelial thickness predicts future visual loss in ...

Pain reduction with linzagolix for uterine fibroids is partly explained by reduced heavy menstrual bleeding and fibroid ...

Giullia Coradetti, MD, offered insight into her research on a post-hoc analysis based on the GATHER 2 clinical trial data for geographic atrophy and age-related macular degeneration.

Delandistrogene moxeparvovec (Elevidys; Sarepta Therapeutics) appeared to protect muscle from progressive damage in patients ...